trending Market Intelligence /marketintelligence/en/news-insights/trending/f2AW7wLbpmfYCq3Ii_0TcQ2 content esgSubNav
In This List

Aphria closes acquisition of Germany's CC Pharma

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Aphria closes acquisition of Germany's CC Pharma

Canadian cannabis company Aphria Inc. completed its previously announced acquisition of Germany-based pharmaceutical distributor CC Pharma GmbH.

Upon closing, former CC Pharma shareholders were paid with €18.9 million cash. They may also receive up to €23.5 million after closing if certain performance milestones are met.

The acquisition is part of Aphria's expansion efforts in Germany and to ultimately establish a pan-European platform incorporating demand, supply and distribution.